<DOC>
	<DOCNO>NCT00765947</DOCNO>
	<brief_summary>This study ass efficacy aliskiren base treatment regimen reach blood pressure ( BP ) target patient mild moderate hypertension . ( defined mean sit Systolic Blood Pressure [ msSBP ] ≥ 140 mmHg &lt; 180 mmHg and/or mean sit Diastolic Blood Pressure [ msDBP ] ≥ 90 &lt; 110 mmHg ) .</brief_summary>
	<brief_title>Efficacy Tolerability Aliskiren-based Treatment Algorithm Patients With Mild Moderate Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Outpatients ≥ 18 year age Patients diagnosis mild moderate hypertension Visit 1 All patient must msSBP ≥ 140 mmHg &lt; 180 mmHg and/or msDBP ≥ 90 mmHg &lt; 110 mmHg mmHg Visit 3 Severe hypertension define msSBP ≥ 180 mmHg and/or msDBP ≥ 110 mmHg Secondary form hypertension Current diagnosis heart failure ( NYHA Class IIIV ) Current angina pectoris require pharmacological therapy ( stable dose oral topical nitrate ) Second third degree heart block without pacemaker Concurrent potentially life threaten arrhythmia symptomatic arrhythmia , atrial fibrillation atrial flutter , 12 month prior Visit 1 Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Essential Hypertension ( mild moderate )</keyword>
</DOC>